TITILAYO OTUNUGA: Open Payments
NPI 1770038374 · DISTRICT HEIGHTS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$363 in 16 payments from 7 companies in 2025. Trend: 2023 $515 · 2024 $294 · 2025 $363
Food & beverage: $363
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $112 |
| GlaxoSmithKline, LLC. | 3 | $67 |
| Novo Nordisk Inc | 3 | $60 |
| PFIZER INC. | 2 | $35 |
| Lilly USA, LLC | 2 | $34 |
| Amgen Inc. | 1 | $29 |
| Exact Sciences Corporation | 1 | $26 |
Products named: JARDIANCE, SHINGRIX, PREVNAR 20, OTEZLA, Cologuard Collection Kit, Ozempic, MOUNJARO.
Industry payments across MD — which companies pay providers there.
